Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: David R Gandara Ravi Salgia Karen L. Reckamp Karen Kelly |
| Publication date | June 23, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |